We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Molecular Basis of Alzheimer’s Disease Determined

By LabMedica International staff writers
Posted on 02 Oct 2013
Print article
Image: Dark field scattering micrograph showing the accumulation of amyloid structures (Photo courtesy of the University of Toronto).
Image: Dark field scattering micrograph showing the accumulation of amyloid structures (Photo courtesy of the University of Toronto).
Alzheimer's disease is thought to be caused by the buildup of abnormal, thread-like protein deposits in the brain, known as beta-amyloid fibrils.

In vitro, β-amyloid (Aβ) peptides form polymorphic fibrils, with molecular structures that depend on growth conditions, including various oligomeric and protofibrillar aggregates.

Scientists at the US National Institute of Health (NIH, Bethesda, MD, USA) working with colleagues from the University of Chicago (IL, USA) investigated structures of human brain-derived Aβ fibrils using seeded fibril growth from brain extract and data from solid-state nuclear magnetic resonance and electron microscopy.

They extracted β-amyloid fibril fragments from the brain tissue of two patients with different clinical histories and degrees of brain damage and then used these fragments to grow a large quantity of fibrils in a dish. They found that a single predominant 40 residue Aβ (Aβ40) fibril structure prevailed in the brain tissue of each patient, but the molecular structures were different between the two patients. A molecular structural model developed for Aβ40 fibrils from one patient reveals features that distinguish in vivo- from in vitro-produced fibrils.

Robert Tycko, PhD, a scientist at the NIH, and senior author of the study, said, “This work represents the first detailed characterization of the molecular structures of beta-amyloid fibrils that develop in the brains of patients with Alzheimer's disease. This detailed structural model may be used to guide the development of chemical compounds that bind to these fibrils with high specificity for purposes of diagnostic imaging, as well as compounds that inhibit fibril formation for purposes of prevention or therapy. This may mean that fibrils in a given patient appear first at a single site in the brain, and then spread to other locations while retaining the identical molecular structure.” The study was published on September 12, 2013, in the journal Cell.

Related Links:
US National Institute of Health
University of Chicago


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
DNA topoisomerase I ELISA
Anti-Scl-70 ELISA Test
New
C-Reactive Protein Test
mLabs CRP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.